Comment: Andexanet alfa: A Novel Factor Xa Inhibitor Reversal Agent

被引：3
|
作者：
Gilbert, Brian W. [1 ]
Reeder, Jacob A. [1 ]
机构：
[1] Wesley Med Ctr, Wichita, KS 67214 USA
来源：
ANNALS OF PHARMACOTHERAPY | 2019年 / 53卷 / 11期
关键词：
D O I：
10.1177/1060028019855160
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1167 / 1167
页数：1
相关论文
共 50 条
  • [21] Andexanet Alfa for Bleeding with Factor Xa Inhibitors
    Ponnusamy, Vignesh
    Sinha, Ankur
    Kupfer, Yizhak
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (02): : 191 - 192
  • [22] Comment on: Andexanet alfa for Acute Major Bleeding Associated with Factor Xa Inhibitors
    Lier, H.
    Grottke, O.
    ANAESTHESIST, 2016, 65 (12): : 940 - 941
  • [23] Utilization and Laboratory Monitoring of Andexanet Alfa Reversal of Factor Xa Inhibitors in Bleeding Patients
    Alipour, Zahra
    Jackups, Ronald
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2020, 154 : S17 - S18
  • [24] COMPARISON OF ANDEXANET ALFA AND 4-FACTOR PROTHROMBIN COMPLEX FOR REVERSAL OF FACTOR XA INHIBITORS
    Stevens, Victoria
    Kiser, Tyree
    MacLaren, Robert
    Reynolds, Paul
    Trujillo, Toby
    Mueller, Scott
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 298 - 298
  • [25] REVERSAL OF DIRECT FACTOR XA INHIBITORS WITH ANDEXANET ALFA PRIOR TO INVASIVE OR SURGICAL PROCEDURES
    Bradshaw, Paige
    Philpott, Carolyn
    Droege, Christopher
    Droege, Molly
    Ernst, Neil
    Foertsch, Madeline
    Harger, Nicole
    Srinivasan, Vasisht
    Winter, Jessica
    Keegan, Shaun
    CRITICAL CARE MEDICINE, 2022, 50 (01) : 450 - 450
  • [26] RISK FACTORS FOR THROMBOISCHEMIC COMPLICATIONS AFTER ANDEXANET ALFA REVERSAL OF FACTOR XA INHIBITORS
    Bradshaw, Paige
    Shouse, Tiffany
    Foertsch, Madeline
    CRITICAL CARE MEDICINE, 2025, 53 (01)
  • [27] Andexanet Alfa for Reversal of Factor Xa Inhibitors in Intracranial Hemorrhage: Observational Cohort Study
    Rauch, Sebastian
    Mueller, Hans-Peter
    Dreyhaupt, Jens
    Ludolph, Albert C.
    Kassubek, Jan
    Althaus, Katharina
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (12)
  • [28] REVERSAL OF FACTOR XA INHIBITORS-INDUCED ANTICOAGULATION IN HEALTHY SUBJECTS BY ANDEXANET ALFA
    Crowther, Mark
    Lu, Genmin
    Conley, Pamela
    Leeds, Janet
    Castillo, Janice
    Levy, Gallia
    Connolly, Stuart
    Curnutte, John
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [29] Andexanet Alfa for the Reversal of Factor Xa Inhibitor Activity: Prespecified Subgroup Analysis of the ANNEXA-4 Study in Japan
    Toyoda, Kazunori
    Arakawa, Shuji
    Ezura, Masayuki
    Kobayashi, Rei
    Tanaka, Yoshihide
    Hasegawa, Shu
    Yamashiro, Shigeo
    Komatsu, Yoji
    Terasawa, Yuka
    Masuno, Tomohiko
    Kobayashi, Hiroshi
    Oikawa, Suzuko
    Yasaka, Masahiro
    JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS, 2024, 31 (03) : 201 - 213
  • [30] ANDEXANET ALFA VERSUS 4-FACTOR PCC FOR REVERSAL OF INTRACRANIAL HEMORRHAGE ASSOCIATED WITH FACTOR XA
    Semon, Gregory
    Straughn, Angela
    Hardman, Claire
    Steel, Barbara
    Ekeh, Akpofure
    CRITICAL CARE MEDICINE, 2021, 49 (01) : 301 - 301
12345